Table 2.

Functional outcomes and symptomatic intracranial hemorrhage (SICH) by tertiles of the triglyceride-glucose (TyG) index.

Models	TyG	N	Events (%)	Age, sex- adjusted of TyG index		Multivariable- adjusted† of TyG index
Variable				OR (95% CI)	p-value	OR (95% CI)	p-value
Unfavorable functional outcome at 90 days	T1	271	63.8% (173/271)	1.00	–	1.00	–
	T2	272	68.0% (185/272)	1.20 (0.84–1.72)	0.3233	1.14 (0.74–1.76)	0.5455
	T3	269	73.6% (198/269)	1.69 (1.16–2.46)	0.0059*	1.76 (1.13–2.76)	0.0132*
Mortality at 90 days	T1	271	8.9% (24/271)	1.00	–	1.00	–
	T2	272	8.5% (23/272)	0.94 (0.52–1.72)	0.8491	1.01 (0.51–2.00)	0.9746
	T3	269	8.2% (22/269)	0.95 (0.51–1.74)	0.8542	1.17 (0.59–2.33)	0.6529
SICH at 24–36 h by NINDS	T1	305	5.9% (18/305)	1.00	–	1.00	–
	T2	303	5.6% (17/303)	0.95 (0.48–1.88)	0.8704	1.21 (0.58–2.55)	0.6091
	T3	305	3.9% (12/305)	0.72 (0.34–1.54)	0.4028	0.93 (0.41–2.13)	0.8715
SICH at 24–36 h by ECASS II	T1	305	2.6% (8/305)	1.00	–	1.00	–
	T2	303	2.6% (8/303)	1.04 (0.38–2.83)	0.9374	1.16 (0.42–3.20)	0.7719
	T3	305	3.3% (10/305)	1.58 (0.60–4.14)	0.3543	1.60 (0.58–4.36)	0.3619
SICH at 24–36 h by SITS-MOST	T1	305	0.7% (2/305)	1.00	–	1.00	–
	T2	303	2.0% (6/303)	3.12 (0.62–15.67)	0.1681	3.37 (0.66–17.14)	0.1442
	T3	305	1.3% (4/305)	2.61 (0.46–14.67)	0.2764	2.19 (0.35–13.74)	0.4033

NINDS, National Institute of Neurological Disorders and Stroke; OR, odds ratio; SITS-MOST, Safe Implementation of Thrombolysis in Stroke-Monitoring Study.

^*Statistically significant at p < 0.05.

^†The multivariate logistic regression analysis was adjusted for age, sex, hypertension, and atrial fibrillation.